Montrusco Bolton Investments Trimmed Pembina Pipeline (PBA) Position By $5.17 Million; Amphastar Pharmaceuticals (AMPH) Shorts Raised By 0.6%

January 14, 2018 - By Hazel Jackson

Montrusco Bolton Investments Inc decreased Pembina Pipeline Corp (PBA) stake by 8.23% reported in 2017Q3 SEC filing. Montrusco Bolton Investments Inc sold 147,850 shares as Pembina Pipeline Corp (PBA)’s stock declined 0.40%. The Montrusco Bolton Investments Inc holds 1.65 million shares with $57.73 million value, down from 1.80 million last quarter. Pembina Pipeline Corp now has $17.53B valuation. The stock increased 0.23% or $0.08 during the last trading session, reaching $35.43. About 455,173 shares traded. Pembina Pipeline Corporation (NYSE:PBA) has risen 15.45% since January 14, 2017 and is uptrending. It has underperformed by 1.25% the S&P500.

Amphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) had an increase of 0.6% in short interest. AMPH’s SI was 2.46 million shares in January as released by FINRA. Its up 0.6% from 2.44 million shares previously. With 317,200 avg volume, 8 days are for Amphastar Pharmaceuticals Incorporated (NASDAQ:AMPH)’s short sellers to cover AMPH’s short positions. The SI to Amphastar Pharmaceuticals Incorporated’s float is 6.81%. The stock increased 2.20% or $0.4 during the last trading session, reaching $18.56. About 170,652 shares traded. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) has risen 8.19% since January 14, 2017 and is uptrending. It has underperformed by 8.51% the S&P500.

Analysts await Pembina Pipeline Corporation (NYSE:PBA) to report earnings on February, 22. They expect $0.42 EPS, up 90.91% or $0.20 from last year’s $0.22 per share. PBA’s profit will be $207.85 million for 21.09 P/E if the $0.42 EPS becomes a reality. After $0.21 actual EPS reported by Pembina Pipeline Corporation for the previous quarter, Wall Street now forecasts 100.00% EPS growth.

Montrusco Bolton Investments Inc increased Telus Corp (NYSE:TU) stake by 403,253 shares to 2.21M valued at $79.38M in 2017Q3. It also upped Toronto Dominion Bk Ont (NYSE:TD) stake by 696,512 shares and now owns 2.50M shares. Canadian Natl Ry Co (NYSE:CNI) was raised too.

Among 5 analysts covering Pembina Pipeline (NYSE:PBA), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Pembina Pipeline had 8 analyst reports since August 10, 2015 according to SRatingsIntel. RBC Capital Markets maintained Pembina Pipeline Corporation (NYSE:PBA) rating on Monday, November 9. RBC Capital Markets has “Outperform” rating and $43 target. The firm has “Buy” rating given on Monday, November 7 by GMP Securities. RBC Capital Markets maintained the shares of PBA in report on Monday, August 10 with “Outperform” rating. JP Morgan initiated the stock with “Overweight” rating in Thursday, October 13 report. The stock of Pembina Pipeline Corporation (NYSE:PBA) has “Neutral” rating given on Monday, June 20 by Credit Suisse. The rating was downgraded by ational Bank Financial on Monday, July 18 to “Sector Perform”. The rating was upgraded by Credit Suisse on Friday, December 11 to “Outperform”.

Among 6 analysts covering Amphastar Pharmaceuticals (NASDAQ:AMPH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Amphastar Pharmaceuticals had 25 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Hold” rating by Raymond James given on Thursday, November 9. The stock has “Buy” rating by Jefferies on Tuesday, August 9. The stock of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) has “Buy” rating given on Monday, August 10 by Zacks. The firm has “Buy” rating by Jefferies given on Friday, October 27. The company was maintained on Friday, September 15 by Piper Jaffray. As per Friday, November 10, the company rating was maintained by BMO Capital Markets. Piper Jaffray maintained the stock with “Buy” rating in Friday, October 20 report. The firm has “Buy” rating given on Tuesday, September 26 by Needham. The firm has “Buy” rating given on Friday, December 1 by Needham. As per Wednesday, August 9, the company rating was maintained by Piper Jaffray.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.